Tag: Atypical Hemolytic Uremic Syndrome

January 16, 2024

Atypical Hemolytic Uremic Syndrome in children and adults

Happy to share with you that our unit at Medanta is now part of International, Multicentric Phase 3 trial on Crovalimab in atypical hemolytic uremic syndrome in children and adults. There’s a need to explore more anti-complement drugs in aHUS. Kindly let us know if you have a patient of atypical HUS including post-partum HUS.

Read More